Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib

Creative Commons License

Reichardt P., Kang Y., Rutkowski P., Schuette J., Rosen L. S., Seddon B., ...More

CANCER, vol.121, no.9, pp.1405-1413, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 121 Issue: 9
  • Publication Date: 2015
  • Doi Number: 10.1002/cncr.29220
  • Journal Name: CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1405-1413
  • Hacettepe University Affiliated: Yes


BACKGROUNDThe objectives of this study were to provide sunitinib to patients with gastrointestinal stromal tumor (GIST) who were otherwise unable to obtain it and to collect broad safety and efficacy data from a large population of patients with advanced GIST after imatinib failure.